Avycaz

Pharma

Is Pfizer buying AZ's antibiotics to beef up for a split?

Fresh off its $14 billion deal for Medivation--and in the midst of considering whether to split in two--Pfizer snapped up a portfolio of high-powered AstraZeneca antibiotics for up to $1.5 billion.

Tracy Staton Aug 24, 2016 7:58am

Allergan says manufacturing issue creates shortage of Avycaz

Aug 15, 2016 2:53pm